Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

Background: A 7‐valent pneumococcal conjugate vaccine (7vPnC) has markedly reduced invasive pneumococcal disease (IPD) in routine use in the USA and is in clinical development in Japan. But a 13‐valent pneumococcal conjugate vaccine (13vPnC) would cover even more serotypes. Because vaccines are admi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics international 2008-06, Vol.50 (3), p.295-299
Hauptverfasser:	Scott, Daniel, Ruckle, Jon, Dar, Marilyn, Baker, Sherryl, Kondoh, Hiroaki, Lockhart, Stephen
Format:	Artikel
Sprache:	eng
Schlagworte:	13 valent 23 valent Adult Antibodies, Anti-Idiotypic - immunology Antibodies, Bacterial - immunology bridging study Clinical outcomes Clinical trials Enzyme-Linked Immunosorbent Assay Female Follow-Up Studies Humans immunogenicity Immunoglobulin G - immunology Incidence Infectious diseases Injections, Subcutaneous Japan - epidemiology Japanese Male Middle Aged Pneumococcal Infections - epidemiology Pneumococcal Infections - microbiology Pneumococcal Infections - prevention & control pneumococcal vaccine Pneumococcal Vaccines - administration & dosage Streptococcus infections Streptococcus pneumoniae Streptococcus pneumoniae - immunology subcutaneous Time Factors Treatment Outcome Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!